A carregar...
Details of risk–benefit communication in informed consent documents for phase I/II trials
BACKGROUND: Informed consent documents for clinical studies should disclose all reasonably foreseeable risks and benefits. Little guidance exists on how to navigate the complexities of risk–benefit communication, especially in early clinical research. Practice-oriented development of such guidance s...
Na minha lista:
| Publicado no: | Clin Trials |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7876653/ https://ncbi.nlm.nih.gov/pubmed/33231107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774520971770 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|